Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,076 public trials 1,849 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

NCT03977467

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - North St. Petersburg, Florida, United States
  • Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
  • Florida Cancer Specialists - East West Palm Beach, Florida, United States
View Trial Details
Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +45 more
Locations
  • Rutgers, The State University of New Jersey New Brunswick, New Jersey, United States
  • New York University Clinical Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

NCT03322540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Florida Cancer Specialists (South Region) Fort Myers, Florida, United States
  • Florida Cancer Specialists (North Region) St. Petersburg, Florida, United States
View all 101 locations
View Trial Details
Completed

A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung

NCT02185690

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details

Related conditions